A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling

Genes and Development

Volumn 16, Issue 6, 2002, Pages 681-686

  Shvarts, Avi ^a   Brummelkamp, Thijn R ^a   Scheeren, Ferenc ^a   Koh, Eugene ^b   Daley, George Q ^b   Spits, Hergen ^a   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

BCL6; Cyclin D1; LAZ3; Lymphoma; p19ARF; p53; Senescence

Indexed keywords

CYCLIN D1; PROTEIN BCL 6; PROTEIN P16; PROTEIN P19;

ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL PROLIFERATION; DNA LIBRARY; FIBROBLAST; GENE IDENTIFICATION; GENETIC SCREENING; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL AGING; CELL DIVISION; CELLS, CULTURED; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FIBROBLASTS; GENE LIBRARY; HUMANS; MICE; MICE, KNOCKOUT; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; RETROVIRIDAE; SIGNAL TRANSDUCTION; TEMPERATURE; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037087737     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.929302     Document Type: Article

References (36)

1. Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications
2. Expression of the BCL6 gene in the pre- and postnatal mouse
3. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40
4. mdm2 expression is induced by wild type p53 activity
5. p14ARF links the turnout suppressors RB and p53
6. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts
7. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor
8. p16 INK4a can initiate an autonomous senescence program
9. 1 control causing immortalization and increased cell turnover under growth-restricting conditions
10. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
11. Association of human cyclin E with a periodic G1-S phase protein kinase
12. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
13. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice
14. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells
15. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
16. Senescence bypass screen identifies TBX2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers
17. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
18. Loss of Cdk2n2A(p16INK4a) confers susceptibility to metastatic melanoma in mice
19. Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis
20. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
21. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
22. Escape from premature senescence is not sufficient for oncogenic transformation by Ras
23. Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages
24. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo
25. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
26. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
27. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
28. Cellular senescence: Mitotic clock or culture shock?
29. MDMX: A novel p53-binding protein with some functional properties of MDM2
30. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
31. The molecular and cellular origins of Hodgkin's disease
32. Gene expression profiling predicts clinical outcome of breast cancer
33. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
34. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
35. Specific protection against breast cancers by cyclin D1 ablation
36. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization